CORRECTION: Kythera Reports FDA Acceptance of ATX-101 NDA, PDUFA Date Set at May 13, 2015
July 10, 2014 at 17:23 PM EDT
KYTHERA Biopharmaceuticals, Inc. (Nasdaq: KYTH) today announced that its New Drug Application (NDA) for ATX-101 (deoxycholic acid), ...